Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes With Chronic Kidney Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01574365
What this trial is testing

RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Kyowa Kirin Co., Ltd. 53
Not applicableEnded earlyNCT05961163
What this trial is testing

Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures: an Observational Study

Who this might be right for
Coronary DiseaseMyocardial InfarctionHeart Failure+13 more
Universitätsklinikum Hamburg-Eppendorf 61
Large-scale testing (Phase 3)Study completedNCT01698775
What this trial is testing

Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 213
Post-approval studies (Phase 4)Not Yet RecruitingNCT07704190
What this trial is testing

Effect of Secukinumab on Cardiorenal Outcomes in Patients With Cardiorenal Metabolic Syndrome and Atherosclerotic Cardiovascular Disease

Who this might be right for
Cardiorenal Metabolic SyndromeAtherosclerotic Cardiovascular DiseaseChronic Kidney Disease+5 more
Peking University Third Hospital 100
Post-approval studies (Phase 4)Not Yet RecruitingNCT07537088
What this trial is testing

Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney Disease

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)CKD - Chronic Kidney Disease
First Affiliated Hospital of Wannan Medical College 468
Not applicableStudy completedNCT04971252
What this trial is testing

Type 2 Diabetes Mellitus and Chronic Kidney Disease

Who this might be right for
Renal Disorder Associated With Type II Diabetes Mellitus
Sohag University 150
Post-approval studies (Phase 4)Study completedNCT05705271
What this trial is testing

Learn How Safe the Study Drug Finerenone is and How Well it Works in Indian People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 2 Diabetes Mellitus

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes Mellitus
Bayer 200
Large-scale testing (Phase 3)Study completedNCT03819153
What this trial is testing

A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 3,533
Early research (Phase 1)Ended earlyNCT01500798
What this trial is testing

A Pharmacodynamic Study of Measured Glomerular Filtration Rate in Patients With Chronic Kidney Disease and Type 2 Diabetes

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Biogen 18
Testing effectiveness (Phase 2)Ended earlyNCT01572610
What this trial is testing

A Glomerular Filtration Rate (GFR) Measuring Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Kyowa Kirin Co., Ltd. 11
Testing effectiveness (Phase 2)Study completedNCT01200394
What this trial is testing

A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy

Who this might be right for
Diabetic Nephropathies
Pfizer 256
Testing effectiveness (Phase 2)WithdrawnNCT01576887
What this trial is testing

A Double-Blind, Randomized, Placebo-Controlled Safety Study Evaluating the Effects of Residual Renal Function (RFF) in Patients With End-Stage Renal Disease and Type 2 Diabetes Mellitus on Peritoneal Dialysis

Who this might be right for
End-Stage Renal DiseaseType 2 Diabetes Mellitus
Biogen
Large-scale testing (Phase 3)Looking for participantsNCT07662135
What this trial is testing

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

Who this might be right for
Type 2 Diabetes MellitusType 2 Diabetes With Chronic Kidney Disease
AstraZeneca 900
Large-scale testing (Phase 3)Study completedNCT00509262
What this trial is testing

Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1)

Who this might be right for
Diabetes Mellitus, Type 2Renal Insufficiency, Chronic
Merck Sharp & Dohme LLC 426
Post-approval studies (Phase 4)Not Yet RecruitingNCT07667517
What this trial is testing

Finerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney Disease

Who this might be right for
AlbuminuriaType 2 Diabetes Mellitus (T2DM)Chronic Kidney Diseases
First Affiliated Hospital of Zhejiang University 148
Large-scale testing (Phase 3)Study completedNCT02065791
What this trial is testing

Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy

Who this might be right for
Diabetes Mellitus, Type 2Diabetic Nephropathy
Janssen Research & Development, LLC 4,401
Testing effectiveness (Phase 2)Study completedNCT01843387
What this trial is testing

Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy

Who this might be right for
Diabetic NephropathyType 2 Diabetes
Mesoblast, Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT01487109
What this trial is testing

Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Disease
Concert Pharmaceuticals 170
Not applicableUnknownNCT06304844
What this trial is testing

Risk of CKD in Diabetic Patients With MAFLD

Who this might be right for
Type 2 Diabetes
Sohag University 300
Not applicableNot Yet RecruitingNCT07668219
What this trial is testing

Efficacy of the Use of Real-time Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes and Stage 3 and 4 Chronic Kidney Disease.

Who this might be right for
Type 2 DiabetesKidney DiseaseCGM+1 more
Hospital Universitario San Ignacio 30
Next Page